<DOC>
	<DOC>NCT01618019</DOC>
	<brief_summary>The purpose of this study is to see if supplementation of n-3 polyunsaturated fatty acid (PUFA) can be beneficial for the patients with rheumatoid arthritis.</brief_summary>
	<brief_title>N-3 PUFA and Rheumatoid Arthritis in Korea</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Patients with rheumatoid arthritis diagnosed based on American College of Rheumatology guideline and receiving NSAID, glucocorticoids, or DMARD were eligible if the dosage had been stable for at least 3 months prior to entering the study. Patients were excluded if they were pregnant, lactating, under the age of 18 or over age 80, taking supplements containing n3 PUFA, white blood cell (WBC) ≤ 3.5 × 109/L, hemoglobin (Hb) ≤ 8.5 g/dL, platelet ≤ 100 × 109/L, creatinine ≥ 2.0 mg/dL, and aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≥ 2.5 times upper limit of normal.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>n-3 PUFA</keyword>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>inflammation</keyword>
	<keyword>eicosanoids</keyword>
	<keyword>bone turnover markers</keyword>
</DOC>